Case 5-2006: recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection.
Faber
Peter
P
Department of Cardiac Anesthesiology, Aberdeen Royal Infirmary, Aberdeen, Scotland. faber@doctors.org.uk <faber@doctors.org.uk>
Reid
Colin
C
El-Shafei
Hussein
H
Falase
Bode
B
DeAnda
Abe
A
Mazer
C David
CD
D000208:Acute Disease; D000784:Aortic Dissection / Q000000981:diagnostic imaging / Q000628:therapy*; D017545:Aortic Aneurysm, Thoracic / Q000000981:diagnostic imaging / Q000628:therapy*; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa